Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FY5GQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,212
Award facts
- Contract value 100% obligated
- $4,212.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of HEPLISAV-B 20 MCG/0.5 ML syringes with a ceiling value of $4,212.40. This competitively awarded, firm fixed-price delivery order was issued on May 27, 2025, with an ultimate completion date of May 28, 2025, and will be performed at the contractor's Conshohocken facility. HEPLISAV-B is a recombinant hepatitis B vaccine used for adult immunization, reflecting the contractor's role in supporting federal medical supply needs for military and veteran healthcare systems.
This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's continued selection as a prime vendor reflects its established capability to meet federal procurement requirements through competitive awards and its critical role in the Defense Health Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FY5GQ?
SPE2DB25FY5GQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 27, 2025.
How much is contract SPE2DB25FY5GQ worth?
The government has obligated $4,212 on SPE2DB25FY5GQ.
Is contract SPE2DB25FY5GQ an order under another contract?
Yes. SPE2DB25FY5GQ is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY5GQ competed?
The extent of competition for SPE2DB25FY5GQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award